Katherine Serrano
Before assuming this role in 2017, Katherine Serrano served nine years in the Office of In Vitro Diagnostics and Radiological Health in Food and Drug Administration’s Center for Devices and Radiological Health’s Office of In Vitro Diagnostics and Radiological Health (CDRH). She began her FDA career as part of the 2008 inaugural class of FDA fellows and has worked as a scientific reviewer and served as the Diabetes Diagnostic Devices Branch Chief and the Deputy Director of FDA’s Division of Chemistry and Toxicology Devices.